Patents by Inventor Ching-Chiang Su

Ching-Chiang Su has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bioavailable compositions of amorphous piperidinyl compounds
    Patent number: 9095585
    Abstract: This invention relates to solid amorphous dispersions comprising Compound I having the formula (formula I), or stereoisomers thereof, and one or more polymers. More particularly, this invention relates to bioavailable amorphous solid dispersions of Compound I that are unexpectedly stable in suspension and in the solid state for extended periods of time that may be used for tabletting.
    Type: Grant
    Filed: July 20, 2012
    Date of Patent: August 4, 2015
    Assignee: Bristol-Myers Squibb Company
    Inventors: Rodney D. Vickery, Kevin J. Stefanski, Ching-Chiang Su, Michael J. Hageman, Balvinder S. Vig, Seema Betigeri
  • Imidazole prodrug LXR modulators
    Patent number: 8901106
    Abstract: Imidazole prodrugs, pharmaceutically acceptable salts, or isomers thereof, of the invention are disclosed, which are useful as modulators of the activity of liver X receptors (LXR). Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.
    Type: Grant
    Filed: March 26, 2012
    Date of Patent: December 2, 2014
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ellen K. Kick, Michael J. Hageman, Victor R. Guarino, Ching-Chiang Su, Chenkou Wei, Jayakumar S. Warrier, Satheesh Nair
  • BIOAVAILABLE COMPOSITIONS OF AMORPHOUS PIPERIDINYL COMPOUNDS
    Publication number: 20140163071
    Abstract: This invention relates to solid amorphous dispersions comprising Compound I having the formula (formula I), or stereoisomers thereof, and one or more polymers. More particularly, this invention relates to bioavailable amorphous solid dispersions of Compound I that are unexpectedly stable in suspension and in the solid state for extended periods of time that may be used for tabletting.
    Type: Application
    Filed: July 20, 2012
    Publication date: June 12, 2014
    Inventors: Rodney D. Vickery, Kevin J. Stefanski, Ching-Chiang Su, Michael J. Hageman, Balvinder S. Vig, Seema Betigeri
  • IMIDAZOLE PRODRUG LXR MODULATORS
    Publication number: 20140018321
    Abstract: Imidazole prodrugs, pharmaceutically acceptable salts, or isomers thereof, of the invention are disclosed, which are useful as modulators of the activity of liver X receptors (LXR). Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.
    Type: Application
    Filed: March 26, 2012
    Publication date: January 16, 2014
    Inventors: Ellen K. Kick, Michael J. Hageman, Victor R. Guarino, Ching-Chiang Su, Chenkou Wei, Jayakumar S. Warrier, Satheesh Nair
  • Pharmaceutical composition having modified carrier
    Patent number: 7829100
    Abstract: A composition comprising: (a) one to three bioactive agents; and (b) a modified liquid vehicle; wherein immediately after manufacture of the composition, said composition can be administered to a host such that the one to three bioactive agents is released to the host on a sustained basis is provided.
    Type: Grant
    Filed: November 10, 2003
    Date of Patent: November 9, 2010
    Inventors: Dirk L. Teagarden, Nancy J. Britten, Scott A. Brown, James F. Caputo, Leslie C. Eaton, Ondrej Hendl, Syed F. Huda, Harry M. King, Susan M. Machkovech, Randal Lee Schapaugh, Stanley M. Speaker, Jean M. Steele, Ching-Chiang Su, Terry R. Urban, Niki A. Waldron, Monica L. Whitmire
  • Pharmaceutical composition having modified carrier
    Publication number: 20040142027
    Abstract: A composition comprising:
    Type: Application
    Filed: November 10, 2003
    Publication date: July 22, 2004
    Inventors: Dirk L. Teagarden, Nancy J. Britten, Scott A. Brown, James F. Caputo, Leslie C. Eaton, Ondrej Hendl, Syed F. Huda, Harry M. King, Susan M. Machkovech, Randal Lee Schapaugh, Stanley M. Speaker, Jean M. Steele, Ching-Chiang Su, Terry R. Urban, Niki A. Waldron, Monica L. Whitmire
  • Parenteral combination therapy for infective conditions
    Publication number: 20030219461
    Abstract: A method is provided for treatment or prevention of an infective condition having an inflammatory component. The method comprises parenteral administration of an antibacterial agent in an antibacterially effective amount, in combination therapy with a selective cyclooxygenase-2 inhibitor in an amount sufficient to provide systemic anti-inflammatory activity. Also provided is a parenterally deliverable pharmaceutical composition comprising an antibacterial agent and a selective COX-2 inhibitor together with one or more excipients.
    Type: Application
    Filed: March 20, 2003
    Publication date: November 27, 2003
    Inventors: Nancy J. Britten, Niki A. Waldron, Thomas J. Yellig, Ching-Chiang Su
  • Pharmaceutical composition having modified carrier
    Publication number: 20020110561
    Abstract: A composition comprising:
    Type: Application
    Filed: September 7, 2001
    Publication date: August 15, 2002
    Inventors: Dirk L. Teagarden, Nancy J. Britten, Scott A. Brown, James F. Caputo, Leslie C. Eaton, Ondrej Hendl, Syed F. Huda, Harry M. King, Susan M. Machkovech, Randal Lee Schapaugh, Stanley M. Speaker, Jean M. Steele, Ching-Chiang Su, Terry R. Urban, Niki A. Waldron, Monica L. Whitmire
  • Magnesium quinolone antibiotics
    Patent number: 6288080
    Abstract: Unique Mg-quinolone complexes are disclosed. They are relatively highly soluble, they may exist as a solution without a precipitate forming and without any need for additional acid or base additions to adjust pH, they may be administered as a subcutaneous or intramuscular injection with a low injection site irritation profile, and they are rapidly absorbed and taken up into the bloodstream.
    Type: Grant
    Filed: November 20, 1998
    Date of Patent: September 11, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Karen Barsuhn, Ching-Chiang Su, Rodney K. Frank
  • Cosolvent parenteral formulation of tirilazad
    Patent number: 5858999
    Abstract: The invention is a cosolvent parenteral pharmaceutical formulation of a lazaroid and its pharmaceutically acceptable salts.
    Type: Grant
    Filed: February 4, 1997
    Date of Patent: January 12, 1999
    Assignee: Pharmacia & Upjohn Company
    Inventors: Ching-Chiang Su, David S. Baker, Susan M. Machkovech
  • Non-hemolytic lazaroid parenteral formulation
    Patent number: 4968675
    Abstract: 16.alpha.-Methyl-21-[4-[2,6-bis(1-pyrrolidinyl)-4-pyrimidinyl]-1-piperaziny l]pregna-1,4,9(11)-triene-3,20-dione monomethanesulfonate causes hemolysis when injected. However, when formulated with a citric acid/sodium citrate both the hemolysis and hypotension side effects are prevented.
    Type: Grant
    Filed: October 28, 1988
    Date of Patent: November 6, 1990
    Assignee: Upjohn
    Inventors: Ching-Chiang Su, Teresa Harshman
  • Clotrimazole cream
    Patent number: 4775678
    Abstract: An oil-in-water cream or lotion emulsion formulation containing clotrimazole having improved antifungal properties containing various amounts of clotrimazole, petrolatum, cetearyl alcohol, propylene glycol, and ceteth-20, with or without other additional ingredients.
    Type: Grant
    Filed: May 8, 1986
    Date of Patent: October 4, 1988
    Assignee: Schering Corporation
    Inventors: Ching-Chiang Su, Joel A. Sequeira